Literature DB >> 30099844

Healthcare utilization in chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

Y M Ende-Verhaar1, W B van den Hout2, H J Bogaard3, L J Meijboom4, M V Huisman1, P Symersky5, A Vonk-Noordegraaf3, F A Klok1.   

Abstract

Essentials Diagnostic delay of chronic thromboembolic pulmonary hypertension (CTEPH) is long. We explored healthcare utilisation of patients diagnosed with CTEPH after pulmonary embolism. A large number of physicians were consulted and test results were not always interpreted correctly. Better education and higher awareness of CTEPH may lead to faster diagnosis.
SUMMARY: Background The median diagnostic delay of chronic thromboembolic pulmonary hypertension (CTEPH) is 14 months, which may affect prognosis. We aimed to explore the healthcare utilization of patients diagnosed with CTEPH after acute pulmonary embolism (PE), and to identify the causes of diagnostic delay. Methods We collected all data on patient symptoms, medical specialist referrals and ordered diagnostic tests to reconstruct the clinical pathways of 40 patients referred to the VU University Medical Center Amsterdam (VUMC, the Netherlands) for CTEPH treatment. Diagnostic delay was defined as the time between first symptom onset and referral to the VUMC. Correlations of patient-specific characteristics and diagnostic delay were evaluated. Results Patients consulted four (median) different physicians for a median of 13 (interquartile range [IQR] 10-18) consultations before the correct diagnosis was made. The median diagnostic delay was 21 months (IQR 12-49 months). Echocardiographic results suggestive of CTEPH were not always followed by an adequate work-up; most patients were not subjected to ventilation/perfusion scanning. Prior cardiopulmonary comorbidity and recurrent venous thromboembolism were predictors of a longer delay. Conclusion Healthcare utilization in patients before their final CTEPH diagnosis was far from optimal, contributing to a considerable diagnostic delay. Better education and higher awareness of CTEPH among PE caretakers may lead to faster diagnosis.
© 2018 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals, Inc. on behalf of International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  chronic thromboembolic pulmonary hypertension; diagnosis; healthcare surveys; pulmonary embolism; time factors

Mesh:

Year:  2018        PMID: 30099844     DOI: 10.1111/jth.14266

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  4 in total

1.  Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism.

Authors:  Gudula J A M Boon; Nienke van Rein; Harm Jan Bogaard; Yvonne M Ende-Verhaar; Menno V Huisman; Lucia J M Kroft; Felix J M van der Meer; Lilian J Meijboom; Petr Symersky; Anton Vonk Noordegraaf; Frederikus A Klok
Journal:  PLoS One       Date:  2020-04-28       Impact factor: 3.240

2.  Prophylaxis and treatment of COVID-19 related venous thromboembolism.

Authors:  F H J Kaptein; M A M Stals; M V Huisman; F A Klok
Journal:  Postgrad Med       Date:  2021-03-04       Impact factor: 3.840

3.  A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension.

Authors:  Gudula J A M Boon; Wilbert B van den Hout; Stefano Barco; Harm Jan Bogaard; Marion Delcroix; Menno V Huisman; Stavros V Konstantinides; Lilian J Meijboom; Esther J Nossent; Petr Symersky; Anton Vonk Noordegraaf; Frederikus A Klok
Journal:  ERJ Open Res       Date:  2021-09-06

4.  A Novel Doppler TRPG/AcT Index Improves Echocardiographic Diagnosis of Pulmonary Hypertension after Pulmonary Embolism.

Authors:  Olga Dzikowska-Diduch; Katarzyna Kurnicka; Barbara Lichodziejewska; Olga Zdończyk; Dominika Dąbrowska; Marek Roik; Szymon Pacho; Maksymilian Bielecki; Piotr Pruszczyk
Journal:  J Clin Med       Date:  2022-02-18       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.